Magnesium Sulfate Sterop

Magnesium sulfate, the active ingredient in Magnesium Sulfate Sterop, is an electrolyte presented as an injection solution for intravenous use. It is used to prevent and treat eclampsia, to act as a tocolytic, to correct magnesium deficiency, and to manage certain cardiac arrhythmias. GNH USA supplies Magnesium Sulfate Sterop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate acts on calcium‑dependent pathways and is employed in several obstetric, metabolic and cardiac conditions. - Eclampsia: prevents seizures and stabilises maternal blood pressure. - Preterm labor: relaxes uterine smooth muscle to delay delivery. - Magnesium deficiency: restores normal serum magnesium concentrations. - Cardiac arrhythmias: helps normalise cardiac electrical activity and reduces ventricular excitability.

Adverse reactions may occur with magnesium sulfate administration.

Common Side Effects: - Flushing or feeling warm - Nausea or vomiting - Headache - Mild hypotension - Muscle weakness or fatigue

Serious or Rare Side Effects: - Respiratory depression or apnea - Severe hypotension or cardiovascular collapse - Hypermagnesemia with cardiac arrest - Allergic or anaphylactoid reactions - Local injection site necrosis or phlebitis

Magnesium sulfate requires careful monitoring in several clinical situations. - Renal impairment: monitor serum magnesium and adjust infusion rate. - Neuromuscular disease (e.g., myasthenia gravis): use with caution due to enhanced blockade. - Cardiac disease: observe ECG for conduction changes. - Pregnancy: administer only under obstetric supervision. - Concomitant calcium‑containing solutions: assess for reduced efficacy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Calcium‑containing IV solutions: may antagonise magnesium effect. - Neuromuscular blocking agents: risk of prolonged paralysis. - Potassium‑sparing diuretics: increase risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: may exacerbate neuromuscular weakness. - ACE inhibitors or ARBs: additive hypotensive effect. - Other magnesium salts: cumulative magnesium load may cause toxicity.